Chilton Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.1M Sell
69,286
-6,945
-9% -$7.1M 2.62% 10
2026
Q1
$70.1M Buy
76,231
+9,101
+14% +$9.23M 2.44% 9
2025
Q4
$72.1M Buy
67,130
+1,082
+2% +$1.03M 2.48% 8
2025
Q3
$50.4M Sell
66,048
-23,634
-26% -$17.6M 1.69% 17
2025
Q2
$69.9M Buy
89,682
+20,251
+29% +$15.7M 2.55% 7
2025
Q1
$57.3M Sell
69,431
-1,143
-2% -$951K 2.47% 8
2024
Q4
$54.5M Buy
70,574
+21,520
+44% +$17.8M 2.29% 8
2024
Q3
$43.5M Buy
49,054
+33,415
+214% +$30M 1.8% 10
2024
Q2
$14.2M Sell
15,639
-22
-0.1% -$17.6K 0.63% 56
2024
Q1
$12.2M Buy
15,661
+29
+0.2% +$20.6K 0.58% 62
2023
Q4
$9.11M Sell
15,632
-1
-0% -$584 0.46% 67
2023
Q3
$8.4M Buy
15,633
+1
+0% +$515 0.47% 68
2023
Q2
$7.33M Hold
15,632
0.4% 70
2023
Q1
$5.37M Hold
15,632
0.31% 75
2022
Q4
$5.72M Hold
15,632
0.36% 73
2022
Q3
$5.05M Hold
15,632
0.34% 75
2022
Q2
$5.07M Hold
15,632
0.31% 75
2022
Q1
$4.48M Hold
15,632
0.23% 81
2021
Q4
$4.32M Hold
15,632
0.22% 84
2021
Q3
$3.61M Hold
15,632
0.2% 89
2021
Q2
$3.59M Buy
+15,632
New +$3.14M 0.21% 85
2014
Q1
Sell
-1,500
Closed -$76.5K 233
2013
Q4
$76.5K Hold
1,500
0.01% 233
2013
Q3
$75.5K Hold
1,500
0.01% 233
2013
Q2
$74K Buy
+1,500
New +$81.6K 0.01% 240

Other funds holding LLY

Chilton Capital Management's LLY Position: Q2 2026 in Review

Chilton Capital Management reduced its Eli Lilly (LLY) stake by 9.1% in Q2 2026, selling an estimated $7.1M and leaving 69,286 shares worth $83.1M. The position accounts for 2.62% of the portfolio, ranked #10.

Chilton Capital Management first reported a position in LLY in Q2 2013 and has held it in 24 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chilton Capital Management held 69,286 shares of Eli Lilly worth $83.1M as of Q2 2026.
  • Chilton Capital Management sold 6,945 Eli Lilly shares in Q2 2026, an estimated $7.1M.
  • Eli Lilly made up 2.62% of Chilton Capital Management's portfolio in Q2 2026, its #10 holding.
  • Chilton Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 24 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.